Insmed (INSM) FCF Margin (2011 - 2026)
Insmed's (INSM) quarterly FCF Margin came in at 73.94% in Q1 2026, up 21926.0% year-on-year from N/an in Q1 2025, and up 24.79% quarter-over-quarter from 98.31% in Q4 2025.
Insmed (INSM) FCF Margin (2011 - 2026) Analysis & Trends
Insmed's FCF Margin history runs 11 years deep, the most recent figure standing at 73.94% for Q1 2026.
- On a quarterly basis, FCF Margin rose 21926.0% year-over-year to 73.94% in Q1 2026; TTM through Mar 2026 was 108.74%, a 9177.0% increase from a year earlier, with the FY2025 full-year figure at 154.54%, up 3120.0% from the prior year.
- FCF Margin improved to 73.94% in Q1 2026 per INSM's latest filing, from 98.31% in the prior quarter.
- Across five years, FCF Margin topped out at 73.94% in Q1 2026 and bottomed at 293.2% in Q1 2025.
- The 5-year median for FCF Margin is 168.64% (2022), against an average of 173.88%.
- Across the five-year window, FCF Margin plunged 7553 bps in 2025 and surged 21926 bps in 2026, its largest moves.
- Year by year, FCF Margin stood at 168.64% in 2022, then rose by 6 bps to 158.88% in 2023, then declined by 16 bps to 185.05% in 2024, then jumped by 47 bps to 98.31% in 2025, then rose by 25 bps to 73.94% in 2026.
- Per Business Quant, the three latest INSM FCF Margin figures stand at 73.94% (Q1 2026), 98.31% (Q4 2025), and 138.08% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | -73.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.94% |
| Dec 31, 2025 | -98.31% |
| Sep 30, 2025 | -138.08% |
| Jun 30, 2025 | -194.62% |
| Mar 31, 2025 | -293.20% |
| Dec 31, 2024 | -185.05% |
| Sep 30, 2024 | -204.43% |
| Jun 30, 2024 | -119.09% |
| Mar 31, 2024 | -243.31% |
| Dec 31, 2023 | -158.88% |
| Sep 30, 2023 | -177.07% |
| Jun 30, 2023 | -164.25% |
| Mar 31, 2023 | -229.55% |
| Dec 31, 2022 | -168.64% |
| Sep 30, 2022 | -145.06% |
| Jun 30, 2022 | -161.31% |
| Mar 31, 2022 | -201.22% |
| Dec 31, 2021 | -182.49% |
| Sep 30, 2021 | -164.52% |
| Jun 30, 2021 | -133.09% |